GLP-1 Receptor Agonists in Pulmonary Hypertension: Mechanistic Rationale, Preclinical Evidence, and Clinical Knowledge Gaps.
- DOI
- 10.1007/s00408-026-00939-2
- Published
- 2026 Sep 16
- Container
- Lung
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00408-026-00939-2,
title = {GLP-1 Receptor Agonists in Pulmonary Hypertension: Mechanistic Rationale, Preclinical Evidence, and Clinical Knowledge Gaps.},
author = {Allaham L and King B and Ali F and Gupta I and Metuku R and Nieto I and Lurie A and Amer FN and Reddy R and Alzghoul B},
year = {2026},
journal = {Lung},
doi = {10.1007/s00408-026-00939-2},
url = {https://doi.org/10.1007/s00408-026-00939-2}
}RIS
TY - JOUR TI - GLP-1 Receptor Agonists in Pulmonary Hypertension: Mechanistic Rationale, Preclinical Evidence, and Clinical Knowledge Gaps. AU - Allaham L AU - King B AU - Ali F AU - Gupta I AU - Metuku R AU - Nieto I AU - Lurie A AU - Amer FN AU - Reddy R AU - Alzghoul B PY - 2026 JO - Lung DO - 10.1007/s00408-026-00939-2 UR - https://doi.org/10.1007/s00408-026-00939-2 ER -
APA
L, A., B, K., F, A., I, G., R, M., I, N., A, L., FN, A., R, R., & B, A. (2026). GLP-1 Receptor Agonists in Pulmonary Hypertension: Mechanistic Rationale, Preclinical Evidence, and Clinical Knowledge Gaps.. Lung. https://doi.org/10.1007/s00408-026-00939-2
Source records
- pubmed · retrieved 2026-09-27T01:08:08.607Z
- europe-pmc · retrieved 2026-09-27T01:08:08.623Z